The report of blood clots without evidence has made Thailand delay the rollout of the AstraZeneca’s Covid-19 vaccine.

The cancellation of the country’s Prime Minister assignment; which was for him to kick off Thailand’s vaccination drive by getting the jab on Friday, is an evidence.

A number of countries, including Denmark and Norway, have also suspended the use of the jab. This happened before the delay in Thailand.

So far, the estimated number of Europeans who have have already received the AstraZeneca vaccine are 5 million.

According to BBC, of this figure, about 30 cases had reported “thromboembolic events” – or developing blood clots.

The European Medicines Agency (EMA) who said, its “benefits continue to outweigh its risks”, confirmed on Thursday that there was no indication the jab was causing the blood clots.

On the safety, AstraZeneca disclosed that the drug has been studied extensively in clinical trials.